Category archives for: Stocks

10% Owner of Medavail Holdings, Inc. (NASDAQ:MDVL), Abg Wtt-Medavail Ltd, buys 7,107 shares worth $99,332

According to Medavail Holdings, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 30 04:30 PM, company 10% Owner, Abg Wtt-Medavail Ltd disclosed buying 7,107 shares at a cost of $13.98. At the time of this transaction (Dec 28), this trade was worth $99,332 in total. […]

Chief Financial Officer of Koss Corp (NASDAQ:KOSS), Smith David Donnan, sells 2,000 shares worth $10,000

According to Koss Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 30 09:03 PM, company Chief Financial Officer, Smith David Donnan disclosed selling 2,000 shares at a cost of $5.00. At the time of this transaction (Dec 29), this trade was worth $10,000 in total. […]

President and CEO of Perma Fix Environmental Services Inc (NASDAQ:PESI), Duff Mark, buys 500 shares worth $2,925

According to Perma Fix Environmental Services Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 30 04:29 PM, company President and CEO, Duff Mark disclosed buying 500 shares at a cost of $5.85. At the time of this transaction (Dec 29), this trade was worth $2,925 […]

CEO and Chairman of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Robins Chad M, sells 16,520 shares worth $981,975

According to Adaptive Biotechnologies Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 30 09:00 PM, company CEO and Chairman, Robins Chad M disclosed selling 16,520 shares at a cost of $59.44. At the time of this transaction (Dec 30), this trade was worth $981,975 in […]

Director of United Insurance Holdings Corp. (NASDAQ:UIHC), Hogan Michael, buys 10,000 shares worth $59,500

According to United Insurance Holdings Corp.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 30 04:11 PM, company Director, Hogan Michael disclosed buying 10,000 shares at a cost of $5.95. At the time of this transaction (Dec 28), this trade was worth $59,500 in total. As […]

CEO and Chairman of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Robins Chad M, sells 16,790 shares worth $995,348

According to Adaptive Biotechnologies Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 30 09:00 PM, company CEO and Chairman, Robins Chad M disclosed selling 16,790 shares at a cost of $59.28. At the time of this transaction (Dec 29), this trade was worth $995,348 in […]

Chief Executive Officer of Golub Capital Bdc, Inc. (NASDAQ:GBDC), Golub David, buys 2,000 shares worth $27,735

According to Golub Capital Bdc, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 30 04:02 PM, company Chief Executive Officer, Golub David disclosed buying 2,000 shares at a cost of $13.87. At the time of this transaction (Dec 29), this trade was worth $27,735 in […]

CEO and Chairman of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Robins Chad M, sells 16,250 shares worth $990,496

According to Adaptive Biotechnologies Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 30 09:00 PM, company CEO and Chairman, Robins Chad M disclosed selling 16,250 shares at a cost of $60.95. At the time of this transaction (Dec 28), this trade was worth $990,496 in […]

Chief Executive Officer of Golub Capital Bdc, Inc. (NASDAQ:GBDC), Golub David, buys 2,000 shares worth $27,742

According to Golub Capital Bdc, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 30 04:02 PM, company Chief Executive Officer, Golub David disclosed buying 2,000 shares at a cost of $13.87. At the time of this transaction (Dec 28), this trade was worth $27,742 in […]

President of Adaptive Biotechnologies Corp (NASDAQ:ADPT), Rubinstein Julie, sells 15,000 shares worth $894,219

According to Adaptive Biotechnologies Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Dec 30 09:00 PM, company President, Rubinstein Julie disclosed selling 15,000 shares at a cost of $59.61. At the time of this transaction (Dec 30), this trade was worth $894,219 in total. As of […]

Featured Press Releases

Photo Gallery

Log in